• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

汉族人与欧洲人在 ZNF804A 功能性变异中的等位基因差异及其与精神分裂症的关联。

Allelic differences between Han Chinese and Europeans for functional variants in ZNF804A and their association with schizophrenia.

机构信息

State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, China.

出版信息

Am J Psychiatry. 2011 Dec;168(12):1318-25. doi: 10.1176/appi.ajp.2011.11030381. Epub 2011 Sep 2.

DOI:10.1176/appi.ajp.2011.11030381
PMID:21890790
Abstract

OBJECTIVE

ZNF804A is a schizophrenia risk gene that was recently identified by genome-wide association studies as well as subsequent replications. Although the results are consistent among studies in European populations, there have been conflicting reports in Chinese populations. The authors conducted both association and functional analyses to test whether ZNF804A is a risk gene for schizophrenia in Chinese populations.

METHOD

The authors recruited two case-control samples of independent Han Chinese (a total of 2,207 participants) from southwestern China. A total of six single-nucleotide polymorphisms (SNPs), including the key SNP (rs1344706) that showed significant association with schizophrenia in European populations and the other five promoter SNPs of ZNF804A, were tested. Based on the results of the association analysis, the authors performed two functional assays to test the impact of the risk SNP on transcriptional factor binding affinity and promoter activity.

RESULTS

The SNP rs1344706 was not associated with schizophrenia in either of the two Han Chinese groups, and this result was confirmed by meta-analyses in five Han Chinese samples. However, the authors identified two ZNF804A promoter SNPs that were significantly associated with schizophrenia in both samples, and the significance was strengthened in the combined samples and further supported by haplotype analysis. The functional assays demonstrated that the risk SNP (rs359895) can influence Sp1 binding affinity, resulting in a higher promoter activity of the risk allele.

CONCLUSIONS

Our results suggest that ZNF804A is a common risk gene for schizophrenia in world populations and that the newly identified functional SNP (rs359895) is likely a risk SNP for schizophrenia.

摘要

目的

ZNF804A 是一个精神分裂症风险基因,最近通过全基因组关联研究以及后续的复制研究得到了证实。尽管在欧洲人群中的研究结果是一致的,但在中国人群中却有相互矛盾的报告。作者进行了关联和功能分析,以测试 ZNF804A 是否是中国人群精神分裂症的风险基因。

方法

作者从中国西南部招募了两个独立的汉族病例对照样本(共 2207 名参与者)。共检测了 6 个单核苷酸多态性(SNP),包括在欧洲人群中与精神分裂症显著相关的关键 SNP(rs1344706)和 ZNF804A 的其他 5 个启动子 SNP。基于关联分析的结果,作者进行了两项功能测定,以测试风险 SNP 对转录因子结合亲和力和启动子活性的影响。

结果

SNP rs1344706 与两个汉族群体中的精神分裂症均无关联,这一结果在五个汉族样本的荟萃分析中得到了证实。然而,作者发现了两个 ZNF804A 启动子 SNP 与两个样本中的精神分裂症显著相关,在合并样本中的显著性得到了加强,并进一步得到了单倍型分析的支持。功能测定表明,风险 SNP(rs359895)可以影响 Sp1 结合亲和力,从而导致风险等位基因的启动子活性更高。

结论

我们的研究结果表明,ZNF804A 是世界人群中常见的精神分裂症风险基因,新发现的功能 SNP(rs359895)可能是精神分裂症的风险 SNP。

相似文献

1
Allelic differences between Han Chinese and Europeans for functional variants in ZNF804A and their association with schizophrenia.汉族人与欧洲人在 ZNF804A 功能性变异中的等位基因差异及其与精神分裂症的关联。
Am J Psychiatry. 2011 Dec;168(12):1318-25. doi: 10.1176/appi.ajp.2011.11030381. Epub 2011 Sep 2.
2
ZNF804A and schizophrenia susceptibility in Asian populations.ZNF804A 与亚洲人群精神分裂症易感性。
Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):794-802. doi: 10.1002/ajmg.b.32084. Epub 2012 Aug 6.
3
Further evidence for the association of genetic variants of ZNF804A with schizophrenia and a meta-analysis for genome-wide significance variant rs1344706.进一步证实 ZNF804A 基因变异与精神分裂症的关联性,以及全基因组显著变异 rs1344706 的荟萃分析。
Schizophr Res. 2012 Oct;141(1):40-7. doi: 10.1016/j.schres.2012.07.013. Epub 2012 Aug 5.
4
Meta-analysis indicates that the European GWAS-identified risk SNP rs1344706 within ZNF804A is not associated with schizophrenia in Han Chinese population.荟萃分析表明,欧洲 GWAS 确定的 ZNF804A 内风险 SNP rs1344706 与汉族人群的精神分裂症无关。
PLoS One. 2013 Jun 12;8(6):e65780. doi: 10.1371/journal.pone.0065780. Print 2013.
5
No association between ZNF804A rs1344706 and schizophrenia in a case-control study of Han Chinese.在中国汉族人群的一项病例对照研究中,ZNF804A基因rs1344706与精神分裂症之间无关联。
Neurosci Lett. 2016 Apr 8;618:14-18. doi: 10.1016/j.neulet.2016.02.048. Epub 2016 Mar 2.
6
A comprehensive meta-analysis of ZNF804A SNPs in the risk of schizophrenia among Asian populations.亚洲人群中ZNF804A基因单核苷酸多态性与精神分裂症风险的综合荟萃分析。
Am J Med Genet B Neuropsychiatr Genet. 2016 Apr;171B(3):437-46. doi: 10.1002/ajmg.b.32425. Epub 2016 Feb 11.
7
The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions.精神分裂症风险基因 ZNF804A:临床关联、生物学机制和神经元功能。
Mol Psychiatry. 2017 Jul;22(7):944-953. doi: 10.1038/mp.2017.19. Epub 2017 Mar 14.
8
Genetic analysis of common variants in the ZNF804A gene with schizophrenia and major depressive disorder.ZNF804A基因常见变异与精神分裂症和重度抑郁症的遗传分析。
Psychiatr Genet. 2018 Feb;28(1):1-7. doi: 10.1097/YPG.0000000000000185.
9
Family-based association study of ZNF804A polymorphisms and autism in a Han Chinese population.汉族人群中ZNF804A基因多态性与自闭症的家系关联研究。
BMC Psychiatry. 2019 May 23;19(1):159. doi: 10.1186/s12888-019-2144-1.
10
Evidence of allelic imbalance in the schizophrenia susceptibility gene ZNF804A in human dorsolateral prefrontal cortex.人类背外侧前额叶皮层中精神分裂症易感基因 ZNF804A 的等位基因失衡证据。
Schizophr Res. 2014 Jan;152(1):111-6. doi: 10.1016/j.schres.2013.11.021. Epub 2013 Dec 7.

引用本文的文献

1
Integration of whole-exome sequencing and structural neuroimaging analysis in major depressive disorder: a joint study.全外显子组测序与结构神经影像学分析在重度抑郁症中的整合:一项联合研究。
Transl Psychiatry. 2024 Mar 9;14(1):141. doi: 10.1038/s41398-024-02849-4.
2
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study.棕榈酸帕利哌酮6个月长效注射剂与棕榈酸帕利哌酮3个月长效注射剂治疗欧洲精神分裂症患者的疗效和安全性:一项全球3期双盲随机非劣效性研究的事后分析
Neuropsychiatr Dis Treat. 2023 Apr 13;19:895-906. doi: 10.2147/NDT.S400342. eCollection 2023.
3
Pharmacogenetics of Antipsychotic Treatment in Schizophrenia.
抗精神病药物治疗精神分裂症的药物遗传学。
Methods Mol Biol. 2022;2547:389-425. doi: 10.1007/978-1-0716-2573-6_14.
4
Association between rs1344706 Polymorphism in the ZNF804A Gene and the Risk for Schizophrenia.锌指蛋白804A(ZNF804A)基因rs1344706多态性与精神分裂症风险的关联。
Iran J Psychiatry. 2021 Oct;16(4):383-388. doi: 10.18502/ijps.v16i4.7225.
5
Regulatory Variant rs2535629 in ITIH3 Intron Confers Schizophrenia Risk By Regulating CTCF Binding and SFMBT1 Expression.ITIH3 内含子中的调控变异 rs2535629 通过调控 CTCF 结合和 SFMBT1 表达增加精神分裂症风险。
Adv Sci (Weinh). 2022 Feb;9(6):e2104786. doi: 10.1002/advs.202104786. Epub 2022 Jan 2.
6
Genome-wide association study followed by trans-ancestry meta-analysis identify 17 new risk loci for schizophrenia.全基因组关联研究后进行跨血统荟萃分析确定了 17 个新的精神分裂症风险位点。
BMC Med. 2021 Aug 12;19(1):177. doi: 10.1186/s12916-021-02039-9.
7
Polymorphism in the ZNF804A Gene and Variation in D and D/D Dopamine Receptor Availability in the Healthy Human Brain: A Dual Positron Emission Tomography Study.ZNF804A 基因多态性与健康人脑内 D 和 D/D 多巴胺受体可用性的变化:一项双重正电子发射断层扫描研究。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 Jan;8(1):121-128. doi: 10.1016/j.bpsc.2020.12.006. Epub 2021 Mar 9.
8
Identification of a functional 339 bp insertion polymorphism in the schizophrenia-associated locus at 10q24.32.鉴定出精神分裂症相关位点 10q24.32 上一个具有功能的 339bp 插入多态性。
Zool Res. 2020 Jan 18;41(1):84-89. doi: 10.24272/j.issn.2095-8137.2020.014.
9
Family-based association study of ZNF804A polymorphisms and autism in a Han Chinese population.汉族人群中ZNF804A基因多态性与自闭症的家系关联研究。
BMC Psychiatry. 2019 May 23;19(1):159. doi: 10.1186/s12888-019-2144-1.
10
A promoter variant in ZNF804A decreasing its expression increases the risk of autism spectrum disorder in the Han Chinese population.一个降低 ZNF804A 表达的启动子变异增加了汉族人群患自闭症谱系障碍的风险。
Transl Psychiatry. 2019 Jan 22;9(1):31. doi: 10.1038/s41398-019-0369-x.